Itron Form 4: Director Perez ups stake to 10,355 shares
Rhea-AI Filing Summary
Itron, Inc. (ITRI) filed a Form 4 disclosing that independent director Santiago Perez received 377 shares of common stock on 07/01/2025. The shares were granted at a price of $0 as part of the company’s regular quarterly equity compensation for non-employee directors. Following the grant, Perez’s direct beneficial ownership increased to 10,355 shares. No derivative securities were involved and there were no dispositions. The filing was signed by attorney-in-fact Christopher E. Ware on 07/02/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine quarterly equity grant; immaterial to float or governance risk.
The 377-share award represents a standard non-cash retainer for outside directors, aligning board interests with shareholders. With an outstanding share count above 40 million, the incremental dilution is negligible. No red flags such as accelerated vesting, option repricing, or large insider sales are present. Governance best practices appear intact because the grant follows a disclosed compensation policy and is reported within the two-business-day SEC window.
TL;DR: Insignificant insider acquisition; no portfolio action warranted.
Perez’s holding rose by roughly 4% to 10,355 shares, but the absolute size (≈ $0.8 million at a $75 share price) is immaterial relative to Itron’s market cap. Because the shares were issued as board compensation rather than an open-market buy, the signal strength is low. The filing does not alter earnings outlook, cash flow, or capital allocation. Therefore, the event is categorized as informational with neutral impact on valuation.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 377 | $0.00 | -- |
Footnotes (1)
- [object Object]